Is Novo Nordisk falling behind Eli Lilly in the weight-loss drug race?

Danish drugmaker Novo Nordisk A/S (CPH: NOVO-B) lost more than 10% last week after its US rival Eli Lilly & Co (NYSE: LLY) reported encouraging Phase 3 data for its…
Input your search keywords and press Enter.